| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.3M | +55.1% |
| R&D Expense | $8.8M | +9.8% |
| SG&A Expense | $24.7M | -18.0% |
| Operating Income | -$32.1M | +13.0% |
| Income Tax | $2K | +100.0% |
| Net Income | -$31.3M | -30.3% |
| EPS (Basic) | -$40.36 | -3291.6% |
| EPS (Diluted) | -$40.36 | -3291.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | -90.3% |
| Accounts Receivable | $1.7M | +53.8% |
| Inventory | $5.9M | -49.0% |
| Current Assets | $13.0M | -59.0% |
| Total Assets | $21.0M | -49.1% |
| Current Liabilities | $8.3M | +5.3% |
| Total Liabilities | $14.0M | -0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.3M | +37.6% |
| Capital Expenditures | $188K | -57.0% |
| Investing Cash Flow | $1.1M | +179.0% |
| Financing Cash Flow | $5.9M | -69.2% |
| Free Cash Flow | -$21.4M | +37.9% |
| Stockholders' Equity |
| $7.5M |
| -72.5% |